Cargando…
Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315962/ https://www.ncbi.nlm.nih.gov/pubmed/32593662 http://dx.doi.org/10.1016/j.drudis.2020.06.022 |
| _version_ | 1783550353139040256 |
|---|---|
| author | Villoutreix, Bruno O. Beaune, Philippe H. Tamouza, Ryad Krishnamoorthy, Rajagopal Leboyer, Marion |
| author_facet | Villoutreix, Bruno O. Beaune, Philippe H. Tamouza, Ryad Krishnamoorthy, Rajagopal Leboyer, Marion |
| author_sort | Villoutreix, Bruno O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7315962 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73159622020-06-25 Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders Villoutreix, Bruno O. Beaune, Philippe H. Tamouza, Ryad Krishnamoorthy, Rajagopal Leboyer, Marion Drug Discov Today Editorial Elsevier Ltd. 2020-08 2020-06-25 /pmc/articles/PMC7315962/ /pubmed/32593662 http://dx.doi.org/10.1016/j.drudis.2020.06.022 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Villoutreix, Bruno O. Beaune, Philippe H. Tamouza, Ryad Krishnamoorthy, Rajagopal Leboyer, Marion Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title_full | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title_fullStr | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title_full_unstemmed | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title_short | Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| title_sort | prevention of covid-19 by drug repurposing: rationale from drugs prescribed for mental disorders |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315962/ https://www.ncbi.nlm.nih.gov/pubmed/32593662 http://dx.doi.org/10.1016/j.drudis.2020.06.022 |
| work_keys_str_mv | AT villoutreixbrunoo preventionofcovid19bydrugrepurposingrationalefromdrugsprescribedformentaldisorders AT beaunephilippeh preventionofcovid19bydrugrepurposingrationalefromdrugsprescribedformentaldisorders AT tamouzaryad preventionofcovid19bydrugrepurposingrationalefromdrugsprescribedformentaldisorders AT krishnamoorthyrajagopal preventionofcovid19bydrugrepurposingrationalefromdrugsprescribedformentaldisorders AT leboyermarion preventionofcovid19bydrugrepurposingrationalefromdrugsprescribedformentaldisorders |